Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Tadalafil NDC 71610-325 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 5 mg - 71610 0324 08
Bottle Label 20 mg - 71610 0325 04
Aphena Pharma Solutions - TN - Aphena
spl-tadalafil-figure-1 - spl tadalafil figure 1
spl-tadalafil-figure-2 - spl tadalafil figure 2
This is a table showing the results of a study that compares the effects of taking Tadalafil 20mg and doxazosin 8mg versus a placebo and doxazosin 8mg on standing and supine systolic blood pressure at different time points after the dose.*
spl-tadalafil-figure-3 - spl tadalafil figure 3
This appears to be a chart or table related to a medical study. It shows the effect of different treatments on systolic blood pressure (measured in mmHg) at different times after administration of tadalafil or placebo. The treatments tested were either a combination of 20 mg tadalafil and 8 mg doxazosin (taken at either 8:00 or 20:00) or doxazosin alone with placebo. The description does not provide information on the purpose of the study or the context in which the data were collected.*
spl-tadalafil-figure-4 - spl tadalafil figure 4
spl-tadalafil-figure-5 - spl tadalafil figure 5
The text describes the change in IPSS total score and the duration of treatment in weeks between Tadalafil 5 mg and Placebo, indicating a statistically significant difference with p<0.01. Therefore, it is a useful description of the comparison between the two treatments for this particular outcome.*
spl-tadalafil-figure-6 - spl tadalafil figure 6
This is a graph showing the change in International Prostate Symptom Score (IPSS) total score over a 12-week treatment duration for tadalafil 5 mg and placebo. The results show a significant improvement in IPSS total score for tadalafil 5 mg compared to placebo (p<0.01).*
spl-tadalafil-figure-8 - spl tadalafil figure 8
The text provides information about the "Change from Baseline in IPSS Total Score" for the duration of the treatment in weeks, comparing the effects of Tadalafil 5 mg versus Placebo. It also indicates a significant difference between the two groups with p<0.01.*
spl-tadalafil-structure - spl tadalafil structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.